Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	18.61	59.83	50.44
Graham Fair Price	-12.80	31.35	35.95
PEG	-65.13	-0.65	1.87
Price/Book	-17.06	4.07	4.90
Price/Cash Flow	18.04	90.34	76.54
Prices/Earnings	19.09	17.77	14.92
Price/Sales	6.32	14.53	13.67
Price/FCF	18.04	90.34	76.54
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.47	0.46	0.44
Operating Margin	-12.06	0.22	0.25
ROA	-28.76	0.04	0.06
ROE	0.08	0.06	-30.36
ROIC	0.07	0.05	-25.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.67	-97.14
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.10	-0.28	176.94
EPS QOQ	0.08	-0.27	241.56
FCF QOQ	1.96	-0.27	-86.36
Revenue QOQ	0.06	-0.19	203.77
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	160.00	206.10	28.81
Days Sales Outstanding (DSO)	63.22	74.37	17.64
Inventory Turnover	0.56	0.44	-22.36
Debt/Capitalization	0.05	0.05	-5.12
Quick Ratio	2.54	2.67	5.18
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	26.44	27.63	4.49
Cash	15.47	16.24	4.97
Capex	-0.31	-0.05	84.01
Free Cash Flow	1.69	1.24	-26.58
Revenue	9.49	7.73	-18.49
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.79	4.00	5.53
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.11	-0.99	11.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating